Discovery of 1 -(5 -br omo pyr azi n-2 -yl )-1 -[3 -(t rif uo rom eth yl)benzyl]urea as a promising anticancer drug via synthesis, characterization, biological screening, and computational studies (original ) (raw )Discovery of 1-(5-bromopyrazin-2-yl)-1-[3-(trifluoromethyl)benzyl]urea as a promising anticancer drug via synthesis, characterization, biological screening, and computational studies
Saba Beigh
Scientific Reports, 2023
View PDFchevron_right
Design, Synthesis and Anticancer Activity of a New Series of N-aryl-N′-[4-(pyridin-2-ylmethoxy)benzyl]urea Derivatives
Ahmad Shumayal
Molecules, 2021
View PDFchevron_right
Antiproliferative Activity, Cell Cycle, and Apoptosis Studies of a Series of 6‐Substituted 9H‐Purin‐9‐yl‐pyridinium Derivatives on a Human Cervical Carcinoma Cell Line
Rosario Sánchez-Martín
ChemMedChem, 2013
View PDFchevron_right
Antiproliferative Activity, Cell Cycle, and Apoptosis Studies of a Series of 6-Substituted 9H -Purin-9-yl-pyridinium Derivatives on a Human Cervical Carcinoma Cell Line
Ana Conejo-garcía
ChemMedChem, 2013
View PDFchevron_right
Synthesis and anticancer activity of ( RS)-9-(2,3-dihydro-1,4-benzoxaheteroin-2-ylmethyl)-9 H-purine
Alberto Ramirez
Solar Energ, 2011
View PDFchevron_right
Molecular – Docking Studies of Potent Anticancer Agent
Sunil Ganatra
Journal of Computer Science & Systems Biology, 2012
View PDFchevron_right
Design, synthesis, anticancer evaluation and molecular docking of new V600EBRAF inhibitors derived from pyridopyrazinone
Prof. Mandava venkata Basaveswara Rao
European Journal of Chemistry, 2016
View PDFchevron_right
Antitumor agents 287. Substituted 4-amino-2H-pyran-2-one (APO) analogs reveal a new scaffold from neo-tanshinlactone with in vitro anticancer activity
Kyoko Nakagawa-goto
Bioorganic & Medicinal Chemistry Letters, 2011
View PDFchevron_right
Exploring the novel heterocyclic derivatives as lead molecules for design and development of potent anticancer agents
Iqbal Azad
Journal of Molecular Graphics & Modelling, 2018
View PDFchevron_right
Design, Molecular Modeling and Synthesis of Some New Purine-diones and Pyridopyrimidine-diones with Anticancer Activity
Alaa Hayallah
JOURNAL OF ADVANCES IN CHEMISTRY
View PDFchevron_right
Synthesis and Molecular Docking Study of 4-(3-(2-Chlorophenyl)-5-(2-Methoxyphenyl)-4,5-Dihydro-1H-Pyrazol-1-yl) Benzenesulfonamide as Antibreast Cancer Agent
Adel Zamri
ALCHEMY Jurnal Penelitian Kimia, 2021
View PDFchevron_right
Discovery of 3,6-disubstituted pyridazines as a novel class of anticancer agents targeting cyclin-dependent kinase 2: synthesis, biological evaluation and in silico insights
Mahmoud Elaasser
Journal of Enzyme Inhibition and Medicinal Chemistry
View PDFchevron_right
Antitumor Agents. 1. Synthesis, Biological Evaluation, and Molecular Modeling of 5 H-Pyrido [3, 2-a] phenoxazin-5-one, a Compound with Potent Antiproliferative …
Antonio Lavecchia
Journal of medicinal …, 2002
View PDFchevron_right
Structure-Based Development of Anticancer Drugs
Mario Bianchet
Structure, 2001
View PDFchevron_right
Synthesis and anticancer activity of (RS)-9-(2,3-dihydro-1,4-benzoxaheteroin-2-ylmethyl)-9H-purines
antonia aranega
European Journal of Medicinal Chemistry, 2011
View PDFchevron_right
Battle tactics against MMP-9; discovery of novel non-hydroxamate MMP-9 inhibitors endowed with PI3K/AKT signaling attenuation and caspase 3/7 activation via Ugi bis-amide synthesis Authors
Manar Ahmed Fouad , Mohammed Salah Ayoup
European Journal of Medicinal Chemistry, 2020
View PDFchevron_right
Anti-Cancer Agents in Medicinal Chemistry
Chinweike Eze
Bentham sciences, 2022
View PDFchevron_right
Design, Synthesis and Anticancer Activity Against the MCF-7 Cell Line of Benzo-Fused 1,4-Dihetero Seven- and Six-Membered Tethered Pyrimidines and Purines
Ana Conejo-garcía
Current Medicinal Chemistry, 2008
View PDFchevron_right
Characterization of a membrane-active anti-tumor agent, UA8967
Komath Damodaran
Investigational New Drugs, 2012
View PDFchevron_right
Design, synthesis and structure–activity relationship study of novel pyrazole-based heterocycles as potential antitumor agents
Korany Ali
European Journal of Medicinal Chemistry, 2010
View PDFchevron_right
Synthesis, in vitro, and in silico studies of novel poly‐heterocyclic compounds bearing pyridine and furan moieties as potential anticancer agents
Hasan Kucukbay
Journal of Molecular Structure, 2023
View PDFchevron_right
Novel series of 1, 5 Benzothiazepine skeleton based compounds as anti-cancer agents -In silico and MTT assay based study
Chennu MMPrasada Rao
View PDFchevron_right
Antitumor Agents. 1. Synthesis, Biological Evaluation, and Molecular Modeling of 5H-Pyrido[3,2-a]phenoxazin-5-one, a Compound with Potent Antiproliferative Activity
Adele Bolognese
Journal of Medicinal Chemistry, 2002
View PDFchevron_right
Discovery of novel anticancer candidates based on a combination strategy of synthesis, characterization, biological activity evaluation, consensus docking and molecular modeling
hend hekal
Journal of the Iranian Chemical Society
View PDFchevron_right
Unveiling the antitumor potential of novel N-(substituted-phenyl)-8-methoxycoumarin-3carboxamides as dual inhibitors of VEGFR2 kinase and cytochrome P450 for targeted treatment of hepatocellular carcinoma
Mariusz Jaremko
Frontiers in Chemistry, 2023
View PDFchevron_right
Synthesis and In Vitro Antiproliferative Activity of New 1-Phenyl-3-(4-(pyridin-3-yl)phenyl)urea Scaffold-Based Compounds
Mohamed E . Shaker
View PDFchevron_right
Design synthesis and evaluation of anticancer activity of heterocyclic compounds
ojaswi ghadge
Shodhganga, 2019
View PDFchevron_right
In Vitro, Molecular Docking, and In Silico Binding Mode Analysis of Organic Compounds for Antimicrobial and Anticancer Activity against Jurkat, HCT116, and A549 Cell Lines
Sanay Naha
ChemistrySelect, 2020
View PDFchevron_right